Related Experiment Video
Updated: Aug 11, 2026
10:32
Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
Published on: January 18, 2016
Stroke, dementia, and drug delivery
G A Ford1, C A Bryant, A A Mangoni
1Department of Health Care of the Elderly, Guy's, King's, and St Thomas' School of Medicine, King's College London, London, UK. g.a.ford@newcastle.ac.uk
British Journal of Clinical Pharmacology
|December 18, 2003
Summary
Stroke and dementia are increasing health burdens in the elderly. This review explores new treatments and research directions, highlighting functional MRI and central nervous system drug delivery challenges.
Area of Science:
- Neurology
- Geriatrics
- Pharmacology
Background:
- Stroke and dementia significantly impact the elderly population, with increasing prevalence due to aging demographics.
- Current therapeutic strategies for stroke and dementia are largely insufficient, hindered by challenges in translating preclinical findings to clinical practice.
Purpose of the Study:
- To review recent advancements in the pathophysiology and treatment of stroke and dementia.
- To discuss functional magnetic resonance imaging (fMRI) as a tool for assessing therapeutic effects and disease progression.
- To provide an overview of challenges and strategies in central nervous system drug delivery.
Main Methods:
- Literature review focusing on recent research in stroke and dementia.
- Detailed discussion of functional magnetic resonance imaging (fMRI) applications.
- Analysis of drug delivery methods for the central nervous system.
Main Results:
- Identified significant challenges in current stroke and dementia treatments.
- Highlighted the potential of fMRI in monitoring treatment efficacy and disease progression.
- Underscored the complexities of achieving effective drug delivery to the central nervous system.
Conclusions:
- There is a critical need for improved therapeutic interventions for stroke and dementia.
- Advanced imaging techniques like fMRI offer promising avenues for research and clinical monitoring.
- Overcoming central nervous system drug delivery barriers is crucial for developing effective treatments.
More Related Videos
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
06:24Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...